Sitagliptin (100mg), Metformin Hydrochloride (1000mg) Sustained Release & Pioglitazone 15 mg

ST GLIPTIN 3D 1000 is a triple-combination oral anti-diabetic medication containing Sitagliptin (100 mg), Metformin Hydrochloride Sustained Release (1000 mg), and Pioglitazone (15 mg). It is prescribed for adults with Type 2 Diabetes Mellitus to help achieve better blood glucose control when diet, exercise, and single or dual-drug therapy are not sufficient. Each ingredient works through a different mechanism, providing comprehensive blood sugar management.

Sitagliptin is a DPP-4 inhibitor that increases incretin hormone activity, helping the body release insulin after meals while reducing excess glucose production by the liver. Metformin SR decreases hepatic glucose production, improves insulin sensitivity, and reduces intestinal glucose absorption. Pioglitazone enhances the body's response to insulin by improving insulin sensitivity in muscle and fat tissues. Together, these medicines help maintain stable blood glucose levels, reduce HbA1c, and lower the risk of long-term diabetes-related complications. ST GLIPTIN 3D 1000 should be used alongside a healthy diet, regular exercise, and routine blood sugar monitoring under medical supervision.

Uses

ST GLIPTIN 3D 1000 is commonly prescribed for:

• Management of Type 2 Diabetes Mellitus in adults.
• Improving glycemic control when dual therapy is inadequate.
• Reducing fasting and post-meal blood glucose levels.
• Lowering HbA1c as part of long-term diabetes management.
• Improving insulin sensitivity and glucose utilization.
• Supporting comprehensive diabetes care with lifestyle modifications.

Benefits

Regular use of ST GLIPTIN 3D 1000 offers several important benefits:

• Provides triple-action blood glucose control.
• Helps reduce fasting and postprandial blood sugar levels.
• Improves insulin sensitivity and pancreatic insulin response.
• Supports long-term HbA1c reduction.
• Sustained-release Metformin offers prolonged glucose control and may improve gastrointestinal tolerability compared with immediate-release formulations in some patients.
• Helps reduce the risk of diabetes-related complications when combined with healthy lifestyle measures.
• Convenient combination tablet that may reduce pill burden.

Dosage

Take ST GLIPTIN 3D 1000 exactly as prescribed by your physician.

General dosage recommendations include:

• Usually taken once daily or as directed by your doctor.
• Swallow the sustained-release tablet whole with water; do not crush, chew, or break it.
• Take with food to help reduce stomach-related side effects.
• Follow a balanced diabetic diet and regular exercise program during treatment.
• Monitor your blood glucose regularly and attend scheduled medical follow-ups.
• Do not stop or change the dose without consulting your healthcare provider.

Side Effects

Like all medicines, ST GLIPTIN 3D 1000 may cause side effects, although not everyone experiences them.

Common side effects include:

• Nausea or stomach discomfort
• Diarrhea
• Headache
• Upper respiratory tract symptoms
• Weight gain (associated with pioglitazone)
• Swelling of the ankles or feet (fluid retention)

Rare but serious side effects include:

• Lactic acidosis (rare but serious)
• Pancreatitis
• Severe allergic reactions
• Liver function abnormalities
• Worsening heart failure in susceptible patients
• Low blood sugar when combined with insulin or sulfonylureas

Seek immediate medical attention if you experience severe abdominal pain, difficulty breathing, or symptoms suggestive of lactic acidosis such as unusual weakness, muscle pain, or rapid breathing.

Precautions and Warnings

Before taking ST GLIPTIN 3D 1000, inform your doctor about your complete medical history.

Important precautions include:

• Use only under medical supervision.
• Not indicated for Type 1 Diabetes Mellitus or diabetic ketoacidosis.
• Inform your doctor if you have kidney disease, liver disease, heart failure, or a history of pancreatitis.
• Regular monitoring of kidney function, liver function, and blood glucose is recommended.
• Limit alcohol consumption, as excessive alcohol intake may increase the risk of lactic acidosis.
• Inform your healthcare provider about all medicines you are taking to avoid potential drug interactions.
• Use during pregnancy or breastfeeding only if advised by your physician.
• Maintain a healthy diet, regular exercise, and weight management for optimal diabetes control.

Conclusion

ST GLIPTIN 3D 1000 (Sitagliptin 100 mg, Metformin Hydrochloride 1000 mg Sustained Release & Pioglitazone 15 mg) is an advanced triple-combination therapy designed to provide comprehensive blood glucose control in adults with Type 2 Diabetes Mellitus. By targeting multiple pathways involved in glucose regulation, it helps improve insulin sensitivity, lower fasting and post-meal blood sugar levels, and support long-term HbA1c management. When used as prescribed alongside a healthy lifestyle, regular blood sugar monitoring, and routine medical follow-up, ST GLIPTIN 3D 1000 can play an important role in effective diabetes management and reducing the risk of long-term complications.